Literature DB >> 19875047

Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor.

Andrea F Armstrong1, Jennifer A Lemon, Shannon K Czorny, Gurmit Singh, John F Valliant.   

Abstract

INTRODUCTION: The aim of this work was to investigate the relative radiolabelling kinetics and affinity of a series of ligands for the [(99m)Tc(CO)(3)](+) core, both in the absence and in the presence of competing donors. This information was used to select a suitable ligand for radiolabelling complex peptide-based targeting vectors in high yield under mild conditions.
METHODS: A series of alpha-N-Fmoc-protected lysine derivatives bearing two heterocyclic donor groups at the epsilon-amine (1a, 2-pyridyl; '1b, quinolyl; '1c, 6-methoxy-2-pyridyl; 1d, 2-thiazolyl; 1e, N-methylimidazolyl; '1f, 3-pyridyl) were synthesized and labelled with (99m)Tc. A resin-capture purification strategy for the separation of residual ligand from the radiolabelled product was also developed. The binding affinities of targeted peptides 4, 5a and 5b for uPAR were determined using flow cytometry.
RESULTS: Variable temperature radiolabelling reactions using 1a-'1f and [(99m)Tc(CO)(3)](+) revealed optimal kinetics and good selectivity for compounds '1a and 1d; in the case of '1a, 1d, and 1e, the labelling can be conducted at ambient temperature. The utility of this class of ligands was further demonstrated by the radiolabelling of a cyclic peptide that is known to target the serine protease receptor uPAR; essentially quantitative incorporation of (99m)Tc occurred exclusively at the SAAC site, despite the presence of a His residue, and without disruption of the disulfide bond.
CONCLUSION: A series of single amino acid chelate (SAAC) ligands have been evaluated for their ability to incorporate (99m)Tc into peptides. The lead agent to emerge from this work is the thiazole SAAC derivative 1d which has demonstrated the ability to regioselectively label the widest range of peptides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875047     DOI: 10.1016/j.nucmedbio.2009.07.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  5 in total

1.  Facile rhenium-peptide conjugate synthesis using a one-pot derived Re(CO)3 reagent.

Authors:  Kullapa Chanawanno; Vinay Kondeti; Joel Caporoso; Sailaja Paruchuri; Thomas C Leeper; Richard S Herrick; Christopher J Ziegler
Journal:  Dalton Trans       Date:  2016-02-10       Impact factor: 4.390

2.  Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.

Authors:  Benjamin B Kasten; Xiaowei Ma; Kai Cheng; Lihong Bu; Winston S Slocumb; Thomas R Hayes; Steven Trabue; Zhen Cheng; Paul D Benny
Journal:  Bioconjug Chem       Date:  2015-12-30       Impact factor: 4.774

Review 3.  Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications.

Authors:  Morten Persson; Andreas Kjaer
Journal:  Clin Physiol Funct Imaging       Date:  2013-04-03       Impact factor: 2.273

Review 4.  Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy.

Authors:  Dan Li; Shuanglong Liu; Hong Shan; Peter Conti; Zibo Li
Journal:  Theranostics       Date:  2013-06-29       Impact factor: 11.556

Review 5.  Structure-driven design of radionuclide tracers for non-invasive imaging of uPAR and targeted radiotherapy. The tale of a synthetic peptide antagonist.

Authors:  Michael Ploug
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.